A tetravalent nanovaccine that inhibits growth of HPV-associated head and neck carcinoma via dendritic and T cell activation.

While the DC3 population exhibited a noticeable upward trend following Qβ-HPVag administration, it is essential to highlight that this increase did not reach statistical significance ( Figure 4 F).

also in 111,027 other papers